|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
153,922,000 |
Market
Cap: |
6.15(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$39.95 - $39.95 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
541,223 |
Total Sell Value |
$0 |
$0 |
$0 |
$15,166,753 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
28 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Guyer David R |
Chief Executive Officer |
|
2015-01-02 |
4 |
OE |
$10.03 |
$150,791 |
D/D |
15,034 |
15,034 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-12-01 |
4 |
AS |
$41.35 |
$625,047 |
D/D |
(15,034) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-12-01 |
4 |
OE |
$10.03 |
$150,791 |
D/D |
15,034 |
15,034 |
|
- |
|
Novo A/s |
10% Owner |
|
2014-11-13 |
4 |
S |
$40.20 |
$39,999,000 |
D/D |
(995,000) |
5,901,819 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2014-10-02 |
4 |
AS |
$38.04 |
$74,749 |
D/D |
(1,965) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-10-02 |
4 |
AS |
$38.52 |
$108,126 |
D/D |
(2,807) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-10-02 |
4 |
OE |
$10.03 |
$28,154 |
D/D |
2,807 |
2,807 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2014-10-01 |
4 |
AS |
$37.14 |
$659,003 |
D/D |
(17,676) |
1,965 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-10-01 |
4 |
AS |
$37.12 |
$456,076 |
D/D |
(12,227) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-10-01 |
4 |
OE |
$10.03 |
$123,138 |
D/D |
12,277 |
12,277 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-09-04 |
4 |
AS |
$38.58 |
$42,708 |
D/D |
(1,107) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-09-04 |
4 |
OE |
$10.03 |
$11,103 |
D/D |
1,107 |
1,107 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2014-09-02 |
4 |
AS |
$37.60 |
$715,479 |
D/D |
(18,986) |
19,641 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-09-02 |
4 |
AS |
$37.58 |
$479,586 |
D/D |
(12,727) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-09-02 |
4 |
OE |
$10.03 |
$127,652 |
D/D |
12,727 |
12,727 |
|
- |
|
Peacock Bruce |
CFO & CBO |
|
2014-09-02 |
4 |
AS |
$37.65 |
$233,631 |
D/D |
(6,191) |
0 |
|
- |
|
Peacock Bruce |
CFO & CBO |
|
2014-09-02 |
4 |
OE |
$1.65 |
$10,228 |
D/D |
6,191 |
6,191 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2014-08-01 |
4 |
AS |
$37.78 |
$717,643 |
D/D |
(18,986) |
38,627 |
|
- |
|
Peacock Bruce |
CFO & CBO |
|
2014-08-01 |
4 |
AS |
$37.77 |
$233,912 |
D/D |
(6,191) |
0 |
|
- |
|
Peacock Bruce |
CFO & CBO |
|
2014-08-01 |
4 |
OE |
$1.65 |
$10,228 |
D/D |
6,191 |
6,191 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-08-01 |
4 |
AS |
$37.80 |
$497,197 |
D/D |
(13,136) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-08-01 |
4 |
OE |
$10.03 |
$131,754 |
D/D |
13,136 |
13,136 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-07-01 |
4 |
AS |
$40.92 |
$617,559 |
D/D |
(15,034) |
0 |
|
- |
|
Guyer David R |
Chief Executive Officer |
|
2014-07-01 |
4 |
OE |
$10.03 |
$150,791 |
D/D |
15,034 |
15,034 |
|
- |
|
Patel Samir Chandrakant |
President |
|
2014-07-01 |
4 |
AS |
$40.89 |
$779,860 |
D/D |
(18,986) |
57,613 |
|
- |
|
459 Records found
|
|
Page 17 of 19 |
|
|